Conference Coverage

Overtreatment common in high-risk diabetes patients


 

AT THE ADA ANNUAL SCIENTIFIC SESSIONS

The Department of Veterans Affairs supported the study. Dr. Pogach reported having no financial conflicts of interest.

bjancin@frontlinemedcom.com

Pages

Recommended Reading

Insulin boosted memory in patients with high-risk Alzheimer's allele
Type 2 Diabetes ICYMI
Would patients open wallets for fewer diabetes drug doses?
Type 2 Diabetes ICYMI
Two meals per day better than six in T2DM
Type 2 Diabetes ICYMI
Children of diabetic mothers at greater risk of overweight as young adults
Type 2 Diabetes ICYMI
Pilot study: Vitamin D promising for diabetic pain
Type 2 Diabetes ICYMI
Octogenarians hard hit by insulin adverse events
Type 2 Diabetes ICYMI
Aging-related functional decline boosts diabetes risk
Type 2 Diabetes ICYMI
Add-on dapagliflozin achieves combined weight/HbA1c reduction more often than glipizide
Type 2 Diabetes ICYMI
Novel insulin/GLP-1 combo succeeds in phase III trial
Type 2 Diabetes ICYMI
Osteoprotegerin ups risk of vascular events in type 1 diabetes
Type 2 Diabetes ICYMI